Aurobindo Pharma Get FDA Nod for Marketing Nafcillin Injections in US

by Kathy Jones on  December 28, 2012 at 5:45 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Hyderabad-based Aurobindo Pharma revealed that it has received an approval from the US Food and Drug Administration to market Nafcillin injections in the United States.
 Aurobindo Pharma Get FDA Nod for Marketing Nafcillin Injections in US
Aurobindo Pharma Get FDA Nod for Marketing Nafcillin Injections in US

Nafcillin injections are used to treat infections caused by penicillinase-producing staphylococci bacteria. Aurobindo said that it has received approval for manufacturing the injections in 1g and 2g vials and in 10g/vial pharmacy bulk package.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive